Loading, please wait ...


News Analytics

is 190711 cervical cancer 800x450.
Progression-free survival (PFS) in both the overall and SCC population was 2.8 and 2.9 months with cemiplimab and chemotherapy, respectively (HR, 0.75 and 0.71) and 2.7 and 2.8 months, respectively, for the patients with adenocarcinoma (HR, 0.91), Tewari said.
Google

Subject Matter

  • Healthcare 77.22%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 22.78%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions